GET THE APP

..

Cardiovascular Diseases & Diagnosis

ISSN: 2329-9517

Open Access

Manish Barman

Al Ahli Hospital,
PO Box 6401, Doha
Qatar

Publications
  • Case Report
    Flecainide Induced Ventricular Arrhythmias in Atrial Fibrillation
    Author(s): Manish Barman and Bendaas DjamelManish Barman and Bendaas Djamel

    Purpose: Flecainide is a class 1C antiarrhythmic drug especially used for the management of supraventricular arrhythmia. Flecainide also has a recognized proarrhythmic effect in patients treated for ventricular tachycardia. It is used to treat a variety of cardiac arrhythmias including paroxysmal fibrillation, Paroxysmal Supraventricular tachycardia and ventricular tachycardia. Flecainide works by regulating the flow of sodium in the heart, causing prolongation of the cardiac action potential. The proarrhythmic effects however noted are not widely reported. Method: We report a case of paroxysmal atrial fibrillation with structurally normal heart who was treated with oral Flecainide. Despite subjective improvement and no adverse events [QTc prolongation] a repeat holter detected him to have multiple short non sustained ventricular arrhythmias.. Read More»
    DOI: 10.4172/2329-9517.1000156

    Abstract PDF

Relevant Topics

Google Scholar citation report
Citations: 427

Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report

Cardiovascular Diseases & Diagnosis peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward